Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria
Open Access
- 14 April 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (4) , 760
Abstract
Objectives: Multidrug-resistant (MDR) Gram-negative bacterial infections have limited treatment options due to the impermeability of the outer membrane. New therapeutic strategies or agents are urgently needed, and combination therapies using existing antibiotics are a potentially effective means to treat these infections. In this study, we examined whether phentolamine can enhance the antibacterial activity of macrolide antibiotics against Gram-negative bacteria and investigated its mechanism of action. Methods: Synergistic effects between phentolamine and macrolide antibiotics were evaluated by checkerboard and time–kill assays and in vivo using a Galleria mellonella infection model. We utilized a combination of biochemical tests (outer membrane permeability, ATP synthesis, ΔpH gradient measurements, and EtBr accumulation assays) with scanning electron microscopy to clarify the mechanism of phentolamine enhancement of macrolide antibacterial activity against Escherichia coli. Results: In vitro tests of phentolamine combined with the macrolide antibiotics erythromycin, clarithromycin, and azithromycin indicated a synergistic action against E. coli test strains. The fractional concentration inhibitory indices (FICI) of 0.375 and 0.5 indicated a synergic effect that was consistent with kinetic time–kill assays. This synergy was also seen for Salmonella typhimurium, Klebsiella pneumoniae, and Actinobacter baumannii but not Pseudomonas aeruginosa. Similarly, a phentolamine/erythromycin combination displayed significant synergistic effects in vivo in the G. mellonella model. Phentolamine added singly to bacterial cells also resulted in direct outer membrane damage and was able to dissipate and uncouple membrane proton motive force from ATP synthesis that, resulted in enhanced cytoplasmic antibiotic accumulation via reduced efflux pump activity. Conclusions: Phentolamine potentiates macrolide antibiotic activity via reducing efflux pump activity and direct damage to the outer membrane leaflet of Gram-negative bacteria both in vitro and in vivo.Keywords
Funding Information
- National Natural Science Foundation of China (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
- Guangdong Major Project of Basic and Applied Basic Research (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
- Local Innovative and Research Teams Project of Guangdong Peral River Talents Program (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
- Laboratory of Lingnan Modern Agriculture Project (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
- Innovation Team Project of Guangdong University (31972735, 2020B0301030007, 32121004, 2019BT02N054, NT2021006, 2019KCXTD001)
This publication has 32 references indexed in Scilit:
- Therapeutic efficacy of phentolamine in the management of severe hand, foot and mouth disease combined with pulmonary edemaExperimental and Therapeutic Medicine, 2017
- From Erythromycin to Azithromycin and New Potential Ribosome-Binding AntimicrobialsAntibiotics, 2016
- A platform for the discovery of new macrolide antibioticsNature, 2016
- Combination approaches to combat multidrug-resistant bacteriaTrends in Biotechnology, 2013
- Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteriaFEMS Microbiology Reviews, 2012
- Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studiesClinical Microbiology and Infection, 2008
- Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin–meropenem combination therapy for multidrug-resistant Gram-negative bacterial infectionsClinical Microbiology and Infection, 2006
- Efflux-Mediated Drug Resistance in BacteriaDrugs, 2004
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003
- Emr, an Escherichia coli locus for multidrug resistance.Proceedings of the National Academy of Sciences, 1992